AIV Logo AIV Assistant

 Logo Danaher Corporation - 0R2B.L 201.89 USD

P/E
0.31
EPS
8.64
Yield
0.59%
P/B
3.88
ROE
7.98
Beta
0.86

201.890 USD

201.890 USD

Daily: +0.00%
Key Metrics

P/E: 0.31

EPS: 8.64

Book Value: 68.92

Price to Book: 3.88

Debt/Equity: 36.49

% Insiders: 10.999%

Growth

Revenue Growth: -0.03%

Earnings Growth: -0.18%

Dividend

Dividend Yield: 0.59%

Annual dividends: 1.13 USD

Ex-Div. Date: June 27, 2025

 Logo About Danaher Corporation - (0R2B.L)

Country: United States

Sector: Health Care

Website: http://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Exchange Ticker
LSE (United Kingdom) 0R2B.L
GER (Germany) DAP.DE
NYQ (United States) DHR
Dividend Yield

0.59%

Annual Dividends

1.13 USD

Next ex. div date

June 27, 2025

Historical Dividends
Year Total Dividends
2026 0.66 USD
2025 1.21 USD
2024 1.05 USD
2023 1.06 USD
2022 0.96 USD
2021 0.81 USD
2020 0.71 USD
2019 0.67 USD
2018 0.62 USD
2017 0.42 USD

Yearly aggregated dividends

Dividends

Danaher Corporation
Jul 25, 2025 Upcoming
Dividend
0.32 USD
Danaher Corporation
Apr 25, 2025 Paid
Dividend
0.32 USD
Danaher Corporation
Jan 31, 2025 Paid
Dividend
0.27 USD
Danaher Corporation
Oct 25, 2024 Paid
Dividend
0.27 USD
Danaher Corporation
Jul 26, 2024 Paid
Dividend
0.27 USD

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion